Update on clinical trials of AFM13 therapy ADC评论 November 8, 2022 On November 3, Affimed announced that it will present an update on the ongoing Phase I/II clinical trial at the ASH Congress. The study was Read More »
Leveraging Azide PEG in Biopharmaceuticals: Uniting Azide Linkers and Click Chemistry October 20, 2023
Tetrazine and Methyltetrazine: Structural Distinctions and Their Roles in Pharmaceutical Research October 8, 2023
An Overview of Cyanine Dyes: Types, Wavelengths, and Applications Across Industries September 19, 2023